MarketPeel
Insider Trading Intelligence
DJ

David Lee Johnson

CRBU
DIRECTOR · CARIBOU BIOSCIENCES, INC. · CIK 0001733883
FILING MIX · LIFETIME91%/9%
BUYS
10
SELLS
1
TOTAL VALUE
$108.3K
COMPANIES
2
ACTIVE SINCE
May 2022
HOLDINGS NOW
90,727
AVG SELL PX
$41.98
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by David Lee Johnson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-3.90%+0.58%-4.48%-4.48%
14d1+100.00%-7.35%-0.60%-6.74%-6.74%
30d1+100.00%-4.52%-3.75%-0.77%-0.77%
60d1+100.00%-10.39%+4.62%-15.01%-15.01%
90d1+100.00%-19.07%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
CRBU · 45,000 shares · as of Feb 20, 2026
011,25022,50033,75045,0002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 10 buys / 1 sellsCOVERAGE · 16 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
VERA
VERA THERAPEUTICS, INC.
SALE
Chief Operating Officer
2,579$41.98$108.3K45,727Feb 23, 2026Feb 25, 2026View →
CRBU
CARIBOU BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
45,00045,000Feb 20, 2026Feb 20, 2026View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,00048,306Feb 4, 2026Feb 6, 2026View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
40,00040,000Feb 4, 2026Feb 6, 2026View →
CRBU
CARIBOU BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
40,50040,500Feb 20, 2025Feb 21, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
53,80053,800Feb 18, 2025Feb 20, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
26,90026,900Feb 18, 2025Feb 20, 2025View →
VERA
VERA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
160,000160,000Jul 1, 2024Jul 3, 2024View →
CRBU
CARIBOU BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
39,50039,500Feb 20, 2024Feb 22, 2024View →
CRBU
CARIBOU BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
21,50021,500Feb 21, 2023Feb 23, 2023View →
CRBU
CARIBOU BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
44,00044,000May 18, 2022May 18, 2022View →
Other insiders · CRBU
Loading peer insiders…
About this filer
CIK 0001733883
ROLE
Director
PRIMARY
CRBU
COMPANIES
2
ACTIVE SINCE
May 2022
MARKETPEEL · /INSIDER/0001733883DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback